The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
To own Kenvue, you need to believe in the resilience of its everyday health brands and its ability to simplify operations while adapting to digital retail. The latest quarter’s higher sales and net income support the near term catalyst of improving profitability, while the biggest current risk of operational complexity and potential restructuring is not materially changed by this single earnings release.
Among recent announcements, the pending merger with Kimberly Clark stands out as most relevant. As Kenvue reports year on year earnings growth, this large transaction could interact with its push to streamline brands and geographies, affecting how quickly any efficiency gains translate into more stable margins and returns.
Yet even with improving earnings, investors should be aware that Kenvue still faces meaningful execution risk around simplifying its complex portfolio and...
Read the full narrative on Kenvue (it's free!)
Kenvue's narrative projects $16.7 billion revenue and $2.3 billion earnings by 2029. This requires 2.9% yearly revenue growth and an earnings increase of about $0.7 billion from $1.6 billion today.
Uncover how Kenvue's forecasts yield a $19.50 fair value, in line with its current price.
Three fair value estimates from the Simply Wall St Community span roughly US$19.50 to about US$30.51 per share, underlining how far opinions can diverge. Against that wide range, the focus on higher recent profitability and ongoing efforts to reduce complexity may be seen very differently in terms of what it could mean for Kenvue’s future performance.
Explore 3 other fair value estimates on Kenvue - why the stock might be worth just $19.50!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com